13 results
·
25ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
eMVFit (MVF-10M)
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
Oticon
FDA UDI
Sbo Hearing A/S·05714464057665·OTICON PLAY PX 2 MINIRITE T C044
BD MICROFINE+ INSULIN SYRINGES
FDA Adverse Event
Malfunction
·BD MEDICAL - DIABETES CARE·Product code FMF·April 26, 2019
AMBU DISPOSABLE PRESSURE MANOMETER
FDA 510(k)
FDA Class 2
·Anesthesiology
RANFAC ASPIRATION NEEDLE WITH ADJUSTABLE GUIDE
FDA 510(k)
FDA Class 2
·Gastroenterology, Urology
SYRINGE 0.5ML 29GA 12.7MM BLISTER 200BX
FDA Adverse Event
Malfunction
·BD MEDICAL - DIABETES CARE·Product code FMF·April 5, 2019
ANIMAS INSULIN INFUSION PUMP
FDA Adverse Event
Malfunction
·ANIMAS CORPORATION·Product code LZG·November 10, 2014
TERUMO CDI 500 BLOOD PARAMETER MONITOR
FDA Adverse Event
Malfunction
·TERUMO CARDIOVASCULAR SYSTEMS CORP.·Product code DRY·August 17, 2011
SPEEDLOCK IMPLANT WITH INSERTER HANDLE
FDA Adverse Event
Malfunction
·ARTHROCARE CORPORATION·Product code MBI·July 17, 2013
BD SYRINGE 0.5ML 29GA 12.7MM BLISTER 200BX
FDA Adverse Event
Malfunction
·BD MEDICAL - DIABETES CARE·Product code FMF·April 2, 2019
CLEO® 90 INFUSION SET
FDA Adverse Event
Injury
·SMITHS MEDICAL ASD, INC.·Product code FPA·May 16, 2017
CLEO® 90 INFUSION SET
FDA Adverse Event
Injury
·SMITHS MEDICAL ASD, INC.·Product code FPA·May 16, 2017
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014